ストックスクリーナーアプリを入手
39.78
0.08%
0.03
アフターアワーズ：
39.78
前日終値:
$39.75
開ける：
$39.73
24時間の取引高:
1.21M
Relative Volume:
0.48
時価総額：
$6.16B
収益：
$15.06M
当期純損益:
$-250.69M
株価収益率:
-22.41
EPS:
-1.7748
ネットキャッシュフロー:
$-209.28M
1週間 パフォーマンス:
+0.20%
1か月 パフォーマンス:
+0.79%
6か月 パフォーマンス:
+37.27%
1年 パフォーマンス:
+209.09%
1日の値動き範囲:
$39.73
$39.81
1週間の範囲:
$39.66
$39.85
52週間の値動き範囲:
$10.95
$40.26
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
名前
Centessa Pharmaceuticals Plc Adr
セクター
電話
44 7391 789784
住所
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
39.78 | 6.15B | 15.06M | -250.69M | -209.28M | -1.7748 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | ダウングレード | Truist | Buy → Hold |
| 2026-02-24 | 開始されました | Wolfe Research | Outperform |
| 2025-12-10 | 再開されました | Oppenheimer | Outperform |
| 2025-10-28 | 開始されました | Stephens | Overweight |
| 2025-09-03 | 開始されました | Wells Fargo | Overweight |
| 2025-08-29 | 再開されました | Oppenheimer | Outperform |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-05-28 | 開始されました | Needham | Buy |
| 2025-05-08 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-31 | 開始されました | Piper Sandler | Overweight |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-09-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-07-18 | 開始されました | Oppenheimer | Outperform |
| 2023-11-15 | アップグレード | Jefferies | Hold → Buy |
| 2023-10-26 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 開始されました | Evercore ISI | Outperform |
| 2023-06-12 | 開始されました | Guggenheim | Buy |
| 2023-03-17 | 開始されました | SVB Securities | Outperform |
| 2022-08-12 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-06-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-02-11 | 開始されました | Goldman | Neutral |
すべてを表示
Centessa Pharmaceuticals Plc Adr (CNTA) 最新ニュース
Eli Lilly, Centessa Pharmaceuticals receive US green light - MLex
HSR waiting period lapses for Centessa (CNTA) sale to Eli Lilly under UK scheme - Stock Titan
LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal - MSN
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plcCNTA - ChartMill
Centessa (NASDAQ: CNTA) to be acquired by Lilly for $38 plus up to $9 CVR - Stock Titan
Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After A 191% One Year Surge? - Yahoo Finance
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 - GlobeNewswire Inc.
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month HighStill a Buy? - MarketBeat
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
Centessa (NASDAQ: CNTA) schedules 2026 AGM and advisory pay vote - Stock Titan
38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April - MarketBeat
Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35 - marketscreener.com
Lilly to buy Centessa (NASDAQ: CNTA) for $38/ share plus $9 CVR - Stock Titan
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - Finviz
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? - Sahm
Free cash flow per share of Centessa Pharmaceuticals PLC ADR – MUN:260 - TradingView
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Sahm
This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next? - Defense World
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) - Sahm
Centessa Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CNTA) - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal - Yahoo Finance
JPMorgan Chase & Co. Sells 186,539 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals Plc Adr (CNTA) 財務データ
収益
当期純利益
現金流量
EPS
Centessa Pharmaceuticals Plc Adr (CNTA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Anderson Karen M. | Chief People Officer |
Mar 26 '26 |
Sale |
30.12 |
41,076 |
1,237,382 |
62,085 |
| Weinhoff Gregory M | Chief Business Officer |
Mar 26 '26 |
Option Exercise |
3.85 |
23,998 |
92,392 |
89,923 |
| Weinhoff Gregory M | Chief Business Officer |
Mar 26 '26 |
Sale |
30.00 |
23,998 |
719,940 |
65,925 |
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):